期刊文献+

乳腺癌中HMGB1蛋白表达及其与Fascin-1的相关性

Expression of HMGB1 protein in breast cancer patients and its correlation with Fascin-1
原文传递
导出
摘要 目的探讨乳腺癌中高迁移率族蛋白B1(HMGB1)蛋白表达及其与Fascin-1蛋白表达的相关性。 方法采用免疫组织化学EnVision法检测98例乳腺癌组织中HMGB1和Fascin-1蛋白的表达及45例正常乳腺组织中HMGB1蛋白的表达情况。结果HMGB1蛋白在乳腺癌组织中阳性率为60.2%(59/98),较正常乳腺组织的15.6%(7/45)显著增强(P〈0.01)。Fascin-1蛋白在乳腺癌组织中阳性率为36.7%(36/98)。HMGB1蛋白阳性乳腺癌患者的Fascin-1蛋白表达率(45.8%,27/59)较HMGB1蛋白阴性患者(23.1%,9/39)显著增强(P〈0.05)。 结论乳腺癌中HMGB1高表达,其可能通过下游信号通路正性调控Fascin-1表达。 ObjectiveTo investigate the expression of high-mobility group box 1 (HMGB1) protein in breast cancer patients and its correlation with Fascin-1 protein expression.MethodsThe immunohistochemical technique, EnVision method, was used to evaluate the expression of HMGB1 and Fascin-1 in 98 patients with breast cancer, and HMGB1 protein was also detected in 45 cases of normal breast tissue.ResultsHMGB1 protein expression rates was significantly higher in breast cancer patients (60.2%, 59/98) than that in normal breast tissue (15.6%, 7/45), P〈0.01. Fascin-1 protein expression rate in breast cancer was (36.7%, 36/98). Fascin-1 expression rates was significantly higher in HMGB1 positive breast cancer cases (45.8%, 27/59) than that in HMGB1 negative cases (23.1%, 9/39), P〈0.05.ConclusionsHMGB1 has high expression in patients with breast cancer, it can positively regulate Fascin-1 expression through the downstream signaling pathways.
作者 王艳 王超群 胡桂女 陈华栋 胡祖良 赵永明 董小芳 黄必飞 Wang Yan;Wang Chaoqun;Hu Guinyu;Chen Huadong;Hu Zuliang;Zhao Yongming;Dong Xiaofang;Huang Bifei(Department of Medical Oncology, Dongyang People's Hospital, Dongyang 322100, China;Department of Pathology, Dongyang People's Hospital, Dongyang 322100, China;Department of Surgical Oncology, Dongyang People's Hospital, Dongyang 322100, China;Department of Pharmacy, Dongyang People's Hospital, Dongyang 322100, Chin;Department of Medical Oncology , Yiwu Tianxiang East Hospital, Yiwu 322000, Chin)
出处 《中国实用医刊》 2018年第11期4-6,共3页 Chinese Journal of Practical Medicine
基金 浙江省医药卫生科技计划项目(2012KYB230)
关键词 高迁移率族蛋白B1 FASCIN-1 乳腺癌 免疫组织化学 High-mobility group box 1 Fascin-1 Breast cancer Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献82

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 2Crispe IN. The Liver as a lymphoid organ. Annu Rev Immunol, 2009,27 : 147-163.
  • 3Rabinovich GA, Gabrilovieh D, Sotomayor EM. lmmunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol, 2007,25:267-296.
  • 4Drake CG, Jaffee E, Pardoll DM. Mechanisms of immune evasion by tumors. Adv Immuno1,2006 ,90 :51-81.
  • 5Maeda S, Hikiba Y, Shibata W, et al. Essential roles of high- mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem Bioph Res Co,2007,360 : 394- 400.
  • 6Liang X, Chavez AR, Schapiro NE, et al. Ethyl pyruvate administration inhibits hepatic tumor growth. J Leukocyte Biol, 2009,86:599-807.
  • 7Lim SC, Choi JE, Kim CH, et al. Ethyl pyruvate induces necrosis- to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells. Int J Mol Med,2007, 20 : 187-192.
  • 8Tang D, Kang R, Xiao W, et aL Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. Am J Respir Cell Mol Bio1,2009 ,41:6514560.
  • 9Hanford LE, Enghild JJ, Valnickova Z, et al. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE), J Biol Chem,200d- ,279:50019-50024.
  • 10Dong Xda E,ho N,Lotze MT,et al. High mobility group box I ( HMGB1 ) release from tumor cells after treatment:implications for development of targeted chemoimmunotherapy. J Immunother, 2007,30:596-606.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部